These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 37220064)
1. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer. Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM J Proteome Res; 2023 Jun; 22(6):2092-2108. PubMed ID: 37220064 [TBL] [Abstract][Full Text] [Related]
2. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer. Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM bioRxiv; 2023 Jan; ():. PubMed ID: 36711577 [TBL] [Abstract][Full Text] [Related]
3. Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model. Huang D; Gaul DA; Nan H; Kim J; Fernández FM J Proteome Res; 2019 Aug; 18(8):3184-3194. PubMed ID: 31290664 [TBL] [Abstract][Full Text] [Related]
4. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model. Jones CM; Monge ME; Kim J; Matzuk MM; Fernández FM J Proteome Res; 2015 Feb; 14(2):917-27. PubMed ID: 25567202 [TBL] [Abstract][Full Text] [Related]
5. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study. Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240 [TBL] [Abstract][Full Text] [Related]
6. Space- and Time-Resolved Metabolomics of a High-Grade Serous Ovarian Cancer Mouse Model. Sah S; Ma X; Botros A; Gaul DA; Yun SR; Park EY; Kim O; Moore SG; Kim J; Fernández FM Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565391 [TBL] [Abstract][Full Text] [Related]
7. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
8. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors. Lanfredi GP; Thomé CH; Ferreira GA; Silvestrini VC; Masson AP; Vargas AP; Grassi ML; Poersch A; Candido Dos Reis FJ; Faça VM Biochim Biophys Acta Proteins Proteom; 2021 Jun; 1869(6):140623. PubMed ID: 33607274 [TBL] [Abstract][Full Text] [Related]
9. The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice. Kim J; Coffey DM; Ma L; Matzuk MM Endocrinology; 2015 Jun; 156(6):1975-81. PubMed ID: 25815421 [TBL] [Abstract][Full Text] [Related]
10. Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer. Medrano M; Communal L; Brown KR; Iwanicki M; Normand J; Paterson J; Sircoulomb F; Krzyzanowski P; Novak M; Doodnauth SA; Saiz FS; Cullis J; Al-Awar R; Neel BG; McPherson J; Drapkin R; Ailles L; Mes-Massons AM; Rottapel R Cell Rep; 2017 Mar; 18(10):2343-2358. PubMed ID: 28273451 [TBL] [Abstract][Full Text] [Related]
11. Ultrahigh Resolution Lipid Mass Spectrometry Imaging of High-Grade Serous Ovarian Cancer Mouse Models. Ma X; Botros A; Yun SR; Park EY; Kim O; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM bioRxiv; 2023 Nov; ():. PubMed ID: 37961688 [TBL] [Abstract][Full Text] [Related]
12. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR. Bapat J; Yamamoto TM; Woodruff ER; Qamar L; Mikeska RG; Aird KM; Watson ZL; Brubaker LW; Bitler BG Cancer Gene Ther; 2024 Feb; 31(2):300-310. PubMed ID: 38030811 [TBL] [Abstract][Full Text] [Related]
14. Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models. Ma X; Botros A; Yun SR; Park EY; Kim O; Park S; Pham TH; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM Front Chem; 2023; 11():1332816. PubMed ID: 38260043 [TBL] [Abstract][Full Text] [Related]
15. Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes. Govindarajan M; Ignatchenko V; Ailles L; Kislinger T Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671461 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging. Sans M; Gharpure K; Tibshirani R; Zhang J; Liang L; Liu J; Young JH; Dood RL; Sood AK; Eberlin LS Cancer Res; 2017 Jun; 77(11):2903-2913. PubMed ID: 28416487 [TBL] [Abstract][Full Text] [Related]
18. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer. Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I Clin Chim Acta; 2018 Jun; 481():108-114. PubMed ID: 29481776 [TBL] [Abstract][Full Text] [Related]
19. Metabolomics Reveals Altered Lipid Metabolism in a Mouse Model of Endometriosis. Dutta M; Anitha M; Smith PB; Chiaro CR; Maan M; Chaudhury K; Patterson AD J Proteome Res; 2016 Aug; 15(8):2626-33. PubMed ID: 27246581 [TBL] [Abstract][Full Text] [Related]